Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127201631 | 12720163 | 1 | I | 20160829 | 20160901 | 20160907 | 20160907 | PER | US-PFIZER INC-2016416605 | PFIZER | 40.00 | YR | F | Y | 0.00000 | 20160907 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127201631 | 12720163 | 1 | PS | IRINOTECAN HCL | IRINOTECAN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | UNK, SINGLE | Y | N46577 | 20571 | SOLUTION FOR INFUSION | |||||||
| 127201631 | 12720163 | 2 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 650 MG, UNK | 0 | 650 | MG | ||||||||
| 127201631 | 12720163 | 3 | C | PONATINIB | PONATINIB | 1 | 416.4 MG, UNK | 0 | 416.4 | MG | |||||||||
| 127201631 | 12720163 | 4 | C | PALONOSETRON | PALONOSETRON | 1 | 0.25 MG, UNK | 0 | .25 | MG | |||||||||
| 127201631 | 12720163 | 5 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 127201631 | 12720163 | 6 | C | LORAZEPAM. | LORAZEPAM | 1 | 0.5 MG, UNK | 0 | .5 | MG | |||||||||
| 127201631 | 12720163 | 7 | C | DOCUSATE | DOCUSATE | 1 | UNK | 0 | |||||||||||
| 127201631 | 12720163 | 8 | C | DOXYCYCLINE. | DOXYCYCLINE | 1 | UNK | 0 | |||||||||||
| 127201631 | 12720163 | 9 | C | IBUPROFEN. | IBUPROFEN | 1 | UNK | 0 | |||||||||||
| 127201631 | 12720163 | 10 | C | OXYCODONE | OXYCODONE | 1 | UNK | 0 | |||||||||||
| 127201631 | 12720163 | 11 | C | ONDANSETRON | ONDANSETRON | 1 | UNK | 0 | |||||||||||
| 127201631 | 12720163 | 12 | C | CELECOXIB. | CELECOXIB | 1 | UNK | 0 | |||||||||||
| 127201631 | 12720163 | 13 | C | MORPHINE | MORPHINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127201631 | 12720163 | 1 | Colon cancer |
| 127201631 | 12720163 | 2 | Premedication |
| 127201631 | 12720163 | 4 | Prophylaxis |
| 127201631 | 12720163 | 5 | Prophylaxis |
| 127201631 | 12720163 | 6 | Premedication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127201631 | 12720163 | Diarrhoea | |
| 127201631 | 12720163 | Hypoaesthesia | |
| 127201631 | 12720163 | Oesophageal spasm | |
| 127201631 | 12720163 | Pharyngeal hypoaesthesia | |
| 127201631 | 12720163 | Speech disorder | |
| 127201631 | 12720163 | Vestibular disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127201631 | 12720163 | 1 | 20160829 | 0 |